(Q41302042)

29 September 2017

title

Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects (English)

1 reference

29 September 2017

0 references

0 references

1 reference

D Papalia

1

1 reference

29 September 2017

M Lunetta

series ordinal

2

1 reference

29 September 2017

M Di Mauro

series ordinal

3

1 reference

29 September 2017

language of work or name

1 reference

1 December 1989

1 reference

Journal of Endocrinological Investigation

29 September 2017

published in

1 reference

29 September 2017

volume

12

1 reference

29 September 2017

issue

11

1 reference

29 September 2017

page(s)

777-782

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03350058

29 September 2017

exact match

0 references

cites work

Hormonal and metabolic responses to an enkephalin analogue in normal man

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Effects of naloxone on prolactin, luteinizing hormone, and cortisol responses to surgical stress in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

The role of opioid peptides in the hormonal responses to acute exercise in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Altered hypothalamic and sympathetic responses to hypoglycaemia in familial obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Impaired hypothalamic control of prolactin secretion in massive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Endocrine disturbances in childhood obesity: Growth-Hormone and cortisol response to insulin induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

beta-Endorphin and beta-lipotropin plasma levels in hirsute women: correlation with body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

The Effect of Naloxone on Endogenous Opioid Regulation of Pituitary Gonadotropins and Prolactin during the Menstrual Cycle*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Brain peptides (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary Gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Opiate receptor blockade and diurnal pituitary and adrenal hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Beta-endorphin attenuates the serum cortisol response to exogenous adrenocorticotropin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Endocrine actions of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350058

Effects of insulin-induced hypoglycemia on the plasma cortisol and growth-hormone levels in obese and diabetic persons

21 January 2018

1 reference

12 December 2020

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

12 December 2020

Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *

1 reference

12 December 2020

Lack of Modulation of Pituitary Hormone Stress Response by Neural Pathways Involving Opiate Receptors*

1 reference

12 December 2020

Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia

1 reference

12 December 2020

Studies off the opiate control of prolactin, GH and TSH

1 reference

12 December 2020

Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man

1 reference

12 December 2020

beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects

1 reference

12 December 2020

Hyperendorphinemia in obese children and adolescents

1 reference

12 December 2020

beta-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects

1 reference

12 December 2020

Stereospecific opiate binding in bovine adrenal medulla

1 reference

12 December 2020

Opiates control ACTH through a noradrenergic mechanism

1 reference

12 December 2020

Short-term hormonal effects of naloxone in man

1 reference

12 December 2020

Effects of Naloxone on Insulin-Induced Release of Pituitary Hormones

1 reference

12 December 2020

Classification of opioid receptors

1 reference

12 December 2020

Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion

1 reference

12 December 2020

Naloxone inhibits exercise-induced release of PRL and GH in athletes

1 reference

12 December 2020

Failure of naloxone to alter exercise-induced growth hormone and prolactin release in normal men

1 reference

12 December 2020

Opioids and hypothalamo-pituitary-adrenocorticotrophic activity in the rat [proceedings]

1 reference

12 December 2020

Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03350058

1 reference

Dimensions Publication ID

29 September 2017

1048901000

0 references

1 reference